{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:45:45Z","timestamp":1786653945333,"version":"build-2736575974"},"reference-count":15,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"8","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Glob Oncol"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>PURPOSE<\/jats:title>\n                    <jats:p>Brazil represents a promising environment for clinical research, supported by a genetically diverse population and established research infrastructure. Despite this, participation in global oncology trials remains limited, with study approval timelines among the contributing factors. Recent regulatory reforms have aimed to streamline review processes. This study evaluated ethical and regulatory approval timelines for oncology trials in Brazil.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>We performed a retrospective analysis using data on regulatory approval timelines for oncology clinical trials managed by Contract Research Organizations in Brazil. A total of 196 phase I-IV trials conducted between 2013 and 2023 were included. Timelines were calculated in days from protocol submission to first response and final decision by the National Commission for Ethics in Research (Comiss\u00e3o Nacional de \u00c9tica em Pesquisa [CONEP]) and the Brazilian Health Regulatory Agency (Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria [ANVISA]). Data were stratified into four periods: (I) preimplementation of ANVISA Collegiate Board Resolutions (Resolu\u00e7\u00f5es da Diretoria Colegiada) 09 and 10\/2015, (II) pre\u2013COVID-19, (III) during COVID-19, and (IV) postpandemic\/current (May 2022-December 2023).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Over the last decade, approval times decreased substantially. ANVISA's mean final approval time fell from 341 days in 2013 to 90 days in 2023, whereas CONEP's decreased from 164 to 141 days. Period analysis showed ANVISA's mean time frame declined from 309 days (period I) to 99 days (period IV). CONEP's mean time frame dropped from 266 days (period I) to 128 days prepandemic, with a slight increase to 172 days in the postpandemic\/current period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>Brazil's regulatory and ethical approval processes have shown significant and sustained improvement. Recent legislation introducing centralized ethical review and mandatory response deadlines is expected to further enhance Brazil's competitiveness in global oncology research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/go-26-00138","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:59:14Z","timestamp":1786651154000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":0,"title":["Decade of Progress: Ethical and Regulatory Approval Timelines for Cancer Clinical Trials in Brazil"],"prefix":"10.1200","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5811-5140","authenticated-orcid":true,"given":"Juliana","family":"Giacomazzi","sequence":"first","affiliation":[{"name":"Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8972-7449","authenticated-orcid":true,"given":"Matheus S.","family":"Rocha","sequence":"additional","affiliation":[{"name":"Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4361-2889","authenticated-orcid":true,"given":"Gustavo","family":"G\u00f6ssling","sequence":"additional","affiliation":[{"name":"Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5149-4481","authenticated-orcid":false,"given":"Arthur","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7306-5428","authenticated-orcid":true,"given":"Taiane F.","family":"Rebelatto","sequence":"additional","affiliation":[{"name":"Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8800-7590","authenticated-orcid":true,"given":"Laura","family":"Voelcker","sequence":"additional","affiliation":[{"name":"Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6021-667X","authenticated-orcid":false,"given":"Carlos","family":"Barrios","sequence":"additional","affiliation":[{"name":"Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6271-105X","authenticated-orcid":true,"given":"Gustavo","family":"Werutsky","sequence":"additional","affiliation":[{"name":"Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"e_1_3_8_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2012.22"},{"key":"e_1_3_8_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000000705"},{"key":"e_1_3_8_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2023.5778"},{"key":"e_1_3_8_5_2","unstructured":"ClinicalTrials.gov https:\/\/www.clinicaltrials.gov\/"},{"key":"e_1_3_8_6_2","unstructured":"PHARMACEUTICAL TRENDS\u2014Top 10 Pharmaceutical Markets Worldwide 2024 https:\/\/www.iqvia.com\/-\/media\/iqvia\/pdfs\/canada\/2024-trends\/english\/top10worldwidesales_24.pdf?utm_source=chatgpt.com"},{"key":"e_1_3_8_7_2","unstructured":"Associa\u00e7\u00e3o Brasileira de Organiza\u00e7\u00f5es Representativas de Pesquisa Cl\u00ednica: ABRACRO Analytics-Dados Regulat\u00f3rios http:\/\/www.abracro-analytics.org.br\/"},{"key":"e_1_3_8_8_2","unstructured":"LEI No 14.874 DE 28 DE MAIO DE 2024 https:\/\/www.planalto.gov.br\/ccivil_03\/_ato2023-2026\/2024\/lei\/l14874.htm"},{"key":"e_1_3_8_9_2","unstructured":"DECRETO No 12.651 DE 7 DE OUTUBRO DE 2025 https:\/\/www.in.gov.br\/en\/web\/dou\/-\/decreto-n-12.651-de-7-de-outubro-de-2025-661020333"},{"key":"e_1_3_8_10_2","unstructured":"Resolu\u00e7\u00e3o da Diretoria Colegiada\u2014RDC no 009 de 20\/02\/2015 https:\/\/anvisalegis.datalegis.net\/action\/ActionDatalegis.php?acao=detalharAto&tipo=RDC&numeroAto=00000009&seqAto=000&valorAno=2015&orgao=RDC\/DC\/ANVISA\/MS&nomeTitulo=codigos&desItem=&desItemFim=&cod_modulo=310&cod_menu=9431"},{"key":"e_1_3_8_11_2","unstructured":"Resolu\u00e7\u00e3o da Diretoria Colegiada\u2014RDC no 10 de 20\/02\/2015 https:\/\/anvisalegis.datalegis.net\/action\/ActionDatalegis.php?acao=detalharAto&tipo=RDC&numeroAto=00000010&seqAto=000&valorAno=2015&orgao=RDC\/DC\/ANVISA\/MS&nomeTitulo=codigos&desItem=&desItemFim=&cod_modulo=310&cod_menu=9431"},{"key":"e_1_3_8_12_2","unstructured":"PORTARIA No 188 DE 3 DE FEVEREIRO DE 2020 https:\/\/www.planalto.gov.br\/ccivil_03\/portaria\/Portaria-188-20-ms.htm"},{"key":"e_1_3_8_13_2","unstructured":"PORTARIA No 913 DE 22 DE ABRIL DE 2022 https:\/\/www.planalto.gov.br\/ccivil_03\/portaria\/prt\/portaria-913-22-ms.htm"},{"key":"e_1_3_8_14_2","first-page":"16","article-title":"Positive changes in the Latin American regulatory environment","volume":"16","author":"Ponce de Le\u00f3n M","year":"2019","unstructured":"Ponce de Le\u00f3n M, Arancibia C, Fagundes P, et al: Positive changes in the Latin American regulatory environment. Regul Rapporteur 16:16-19, 2019","journal-title":"Regul Rapporteur"},{"key":"e_1_3_8_15_2","volume-title":"Uso emergencial de vacinas: Anvisa estabelece prazo de at\u00e9 10 dias para dar decis\u00e3o","year":"2020","unstructured":"Uso emergencial de vacinas: Anvisa estabelece prazo de at\u00e9 10 dias para dar decis\u00e3o. Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria - Anvisa, 2020 https:\/\/www.gov.br\/anvisa\/pt-br\/assuntos\/noticias-anvisa\/2020\/uso-emergencial-de-vacinas-anvisa-estabelece-prazo-de-ate-10-dias-para-dar-decisao"},{"key":"e_1_3_8_16_2","first-page":"7","article-title":"Plataforma Brasil: limites e desafios","volume":"12","author":"Loretto NRM","year":"2012","unstructured":"Loretto NRM: Plataforma Brasil: limites e desafios. Revista de Cirurgia e Traumatologia Buco-maxilo-facial 12:7-9, 2012","journal-title":"Revista de Cirurgia e Traumatologia Buco-maxilo-facial"}],"container-title":["JCO Global Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/GO-26-00138","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:59:22Z","timestamp":1786651162000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/GO-26-00138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1200\/GO-26-00138"],"URL":"https:\/\/doi.org\/10.1200\/go-26-00138","relation":{},"ISSN":["2687-8941"],"issn-type":[{"value":"2687-8941","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"2026-02-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-07","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2600138"}}